Synlett 1996; 1996(5): 452-454
DOI: 10.1055/s-1996-5464
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Effective Synthesis of Four Isomeric Trehalose Dicorynomycolates (TDCMs) and Their Immunoadjuvant Activities

Mugio Nishizawa1 , Dulce M. García, Ryutaro Minagawa, Yohko Noguchi, Hiroshi Imagawa, Hidetoshi Yamada, Ryosuke Watanabe, Yung Choon Yoo, Ichiro Azuma2
  • 1Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770, Japan, Fax 81-886-55-3051; E-mail
  • 2Institute of Immunological Science, Hokkaido University, Sapporo 060, Japan, Fax 81-11-709-6482, E-mail
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Four stereoisomers of trehalose 6,6’-dicorynomycolate (TDCM) have been synthesized by using Noyori’s BINAP-Ru catalyzed asymmetric hydrogenation of a racemic β-ketolactone in very high diastereo- and enantio-selectivity as the key step. TDCM with RR fatty acid showed indistinguishable 1H NMR with that isolated from Corynebacterium matruchotii. Although all four stereoisomers of TDCM showed immunoadjuvant activity, natural RR TDCM as well as artificial SS TDCM showed significant activities.